<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref54">
 <mixed-citation publication-type="journal" id="cit54">
  <name>
   <surname>Oberli</surname>
   <given-names>M. A.</given-names>
  </name>; 
  <name>
   <surname>Reichmuth</surname>
   <given-names>A. M.</given-names>
  </name>; 
  <name>
   <surname>Dorkin</surname>
   <given-names>J. R.</given-names>
  </name>; 
  <name>
   <surname>Mitchell</surname>
   <given-names>M. J.</given-names>
  </name>; 
  <name>
   <surname>Fenton</surname>
   <given-names>O. S.</given-names>
  </name>; 
  <name>
   <surname>Jaklenec</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Anderson</surname>
   <given-names>D. G.</given-names>
  </name>; 
  <name>
   <surname>Langer</surname>
   <given-names>R.</given-names>
  </name>; 
  <name>
   <surname>Blankschtein</surname>
   <given-names>D.</given-names>
  </name>
  <article-title>Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy</article-title>. 
  <source>Nano Lett.</source>
  <year>2017</year>, 
  <volume>17</volume>, 
  <fpage>1326</fpage>â€“
  <lpage>1335</lpage>. 
  <pub-id pub-id-type="doi">10.1021/acs.nanolett.6b03329</pub-id>.
  <pub-id pub-id-type="pmid">28273716</pub-id>
 </mixed-citation>
</ref>
